Systematic review of the use of translated patient-reported outcome measures in cancer trials

BACKGROUND: Patient-reported outcomes (PROs) are used in clinical trials to assess the effectiveness and tolerability of interventions. Inclusion of participants from different ethnic backgrounds is essential for generalisability of cancer trial results. PRO data collection should include appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Slade, A. L., Retzer, A., Ahmed, K., Kyte, D., Keeley, T., Armes, J., Brown, J. M., Calman, L., Gavin, A., Glaser, A. W., Greenfield, D. M., Lanceley, A., Taylor, R. M., Velikova, G., Turner, G., Calvert, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074490/
https://www.ncbi.nlm.nih.gov/pubmed/33902699
http://dx.doi.org/10.1186/s13063-021-05255-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074490/
https://www.ncbi.nlm.nih.gov/pubmed/33902699
http://dx.doi.org/10.1186/s13063-021-05255-z

Ejemplares similares